Publications by authors named "Mary Guilfoyle"

Claim this Profile
M
Mitigation of total body irradiation-induced mortality and hematopoietic injury of mice by a thrombopoietin mimetic (JNJ-26366821).
Vidya P Kumar, Gregory P Holmes-Hampton, Shukla Biswas, Sasha Stone, Neel Kamal Sharma, Mary Guilfoyle

Sci Rep· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease.
Sheila K Pierson, Sushila Shenoy, Ana B Oromendia, Alexander M Gorzewski, Ruth-Anne Langan Pai, Mary Guilfoyle

Blood Adv· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma.
Timothy A Brighton, Amit Khot, Simon J Harrison, David Ghez, Brendan M Weiss, Mary Guilfoyle

Clin Cancer Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of response to anti-IL6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease: secondary analyses of phase II clinical trial data.
Deanna E Morra, Sheila K Pierson, Dustin Shilling, Sepideh Nemat, Carlos Appiani, Mary Guilfoyle

Br J Haematol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of erythropoietin in critically ill subjects.
Abhijit Chakraborty, Jaya Natarajan, Mary Guilfoyle, Nancy Morgan, Els Vercammen

J Clin Pharmacol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis